If configured correctly, dashboards give a visual, condensed and up to date view of a process, in our case of the trial enrollment procedure. To reach that result, information developed in different parts of the platform are collated,processed and finally displayed together.
What is the Allyfe team trying to achieve with these dashboards?
They want this one screen to allow a comprehensive approach of the enrolment situation, revealing malfunctions as well as differentiated outcomes, and facilitating counteractions. Dashboards are efficient and intuitive managemen tools.
The Allyfe platform sets up three different integrated dashboards: one for the sponsor, one for the investigator and one for the patient. Each one meets its user's needs and legal constraints.
The sponsor dashboard only includes aggregate numbers of anonymized patients. These aggregate numbers can be filtered by participating country and then by research site in the selected country.
The dashboard indicates the enrolment target for each site and the proportion of the target already reached. It calculates by linear regression how long it will take to meet the target at the current enrolment pace. It is updated inreal time, allowing the sponsor to monitor and compare enrolment performances across different research sites.
It also displays the number of self-eligibility questionnaires (a feature we will develop in a future post….) received, revealing the attractivity of recruitment campaigns.
Figures by step in the enrolment procedure are listed on the lower part of the screen. Each line is divided into patients who have successfully completed that step, those who are going through the step and those who have failed the step (which can help to assess the restrictive nature of exclusion criteria).
The number of terminated and withdrawn patients at the bottom of the screen complete the trial’s general performance context.
The investigator dashboard lists all the steps and sub steps of the enrolment procedure (because of space restrictions, only a few steps are displayed on the screen capture above!), and the number of patients at each (sub)step. The investigator can visualize th elist of patients in each step and each substep: for instance, if he looks into the qualification steps, he can see the list of patients whose qualification has been confirmed, denied, and is ongoing.
The dashboard also gives the investigator direct access to each patient’s records and allows to take action (for instance, confirm eligibility) to a specific patient or even a group of patients.
The patient’s dashboard summarizes the stage reached by each patient in the enrolment procedure, what the next step will be and who needs to take action. It also lists scheduled meetings and available documents, if appropriate.
How does this functionality benefit….
…..the patient:it gives the patient specific and contextual information on where he/she is in the enrolment procedure, what he/she needs to do or what he/she can expect from the investigator. He/she is no longer a passive subject, but an actor of theclinical trial, which enhances his/her engagement and contributes to reducing dropout risks.
…..the investigator: it gives the investigator immediate visibility on where he/she stands vis-à-vis sponsor expectations and patient progress. It also saves time: immediate and even group action on every step of the enrolment procedure is only one click away and electronic storage is automatic.
….the sponsor: sponsors get up to date information on how each site performs on every clinical trial enrolment, allowing them to take immediate action in case of malfunction and triggering thorough benchmarking between research sites. The dashboard is a powerful trial optimization tool.
Do you like our blog posts? Do not hesite to subscribe to the Allyfe company page on LinkedIn. You will be notified of the publication of every issue!